ARTICLE | Company News
Boston Oncology LLC, Oncobiologics deal
November 12, 2012 8:00 AM UTC
Boston Oncology received rights in the Middle East and North African regions to develop and commercialize four undisclosed biosimilars to treat cancer and immunological diseases from Oncobiologics. On...